Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK.
Barts Health NHS Trust, London, UK.
Crit Care. 2023 Jan 17;27(1):25. doi: 10.1186/s13054-022-04279-4.
In-hospital acute resuscitation in trauma has evolved toward early and balanced transfusion resuscitation with red blood cells (RBC) and plasma being transfused in equal ratios. Being able to deliver this ratio in prehospital environments is a challenge. A combined component, like leukocyte-depleted red cell and plasma (RCP), could facilitate early prehospital resuscitation with RBC and plasma, while at the same time improving logistics for the team. However, there is limited evidence on the clinical benefits of RCP.
To compare prehospital transfusion of combined RCP versus RBC alone or RBC and plasma separately (RBC + P) on mortality in trauma bleeding patients.
Data were collected prospectively on patients who received prehospital transfusion (RBC + thawed plasma/Lyoplas or RCP) for traumatic hemorrhage from six prehospital services in England (2018-2020). Retrospective data on patients who transfused RBC from 2015 to 2018 were included for comparison. The association between transfusion arms and 24-h and 30-day mortality, adjusting for age, injury mechanism, age, prehospital heart rate and blood pressure, was evaluated using generalized estimating equations.
Out of 970 recruited patients, 909 fulfilled the study criteria (RBC + P = 391, RCP = 295, RBC = 223). RBC + P patients were older (mean age 42 vs 35 years for RCP and RBC), and 80% had a blunt injury (RCP = 52%, RBC = 56%). RCP and RBC + P were associated with lower odds of death at 24-h, compared to RBC alone (adjusted odds ratio [aOR] 0.69 [95%CI: 0.52; 0.92] and 0.60 [95%CI: 0.32; 1.13], respectively). The lower odds of death for RBC + P and RCP vs RBC were driven by penetrating injury (aOR 0.22 [95%CI: 0.10; 0.53] and 0.39 [95%CI: 0.20; 0.76], respectively). There was no association between RCP or RBC + P with 30-day survival vs RBC.
Prehospital plasma transfusion for penetrating injury was associated with lower odds of death at 24-h compared to RBC alone. Large trials are needed to confirm these findings.
创伤院内急救已朝着早期和平衡的输血复苏方向发展,红细胞(RBC)和血浆以相等的比例进行输注。在院前环境中提供这种比例是一个挑战。一种复合成分,如去白细胞的红细胞和血浆(RCP),可以在早期进行院前复苏,同时改善团队的后勤工作。然而,关于 RCP 的临床益处的证据有限。
比较创伤性出血患者院前输注复合 RCP 与单独输注 RBC 或 RBC 和血浆(RBC+P)对死亡率的影响。
从英格兰六个院前服务机构(2018-2020 年)收集接受院前输血(RBC+解冻血浆/Lyoplas 或 RCP)的创伤性出血患者的数据。还纳入了 2015 年至 2018 年输注 RBC 的患者的回顾性数据进行比较。使用广义估计方程评估输血组与 24 小时和 30 天死亡率之间的关联,调整因素包括年龄、损伤机制、年龄、院前心率和血压。
在招募的 970 名患者中,有 909 名符合研究标准(RBC+P=391,RCP=295,RBC=223)。RBC+P 患者年龄较大(平均年龄为 42 岁,RCP 为 35 岁,RBC 为 35 岁),80%为钝性损伤(RCP 为 52%,RBC 为 56%)。与单独输注 RBC 相比,RCP 和 RBC+P 在 24 小时时死亡的可能性较低(调整后的优势比[OR]分别为 0.69 [95%CI:0.52;0.92]和 0.60 [95%CI:0.32;1.13])。RBC+P 和 RCP 与 RBC 相比,死亡可能性较低的原因是穿透性损伤(OR 分别为 0.22 [95%CI:0.10;0.53]和 0.39 [95%CI:0.20;0.76])。RCP 或 RBC+P 与 30 天生存率与 RBC 之间没有关联。
与单独输注 RBC 相比,院前输注血浆治疗穿透性损伤与 24 小时死亡率降低相关。需要进行大型试验来证实这些发现。